Concepedia
Statistics
Publications
5
Citations
161
H-Index
Active since
2015
Affiliations
Meharry Medical College(Current)
Vanderbilt University
The Ohio State University
University of California, Davis
Leidos (United States)
Duafalia F. Dudimah is an author at Meharry Medical College specializing in immunology, oncology, and cancer immunotherapy.
Publications per year
2015–2016
Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy
Asel K. Biktasova, Duafalia F. Dudimah, Roman V. Uzhachenko et al. · Cancer Research · 2015 · 60 citations · Full text
Life Sciences, Immunology, Oncology +17
Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk
Menaka C. Thounaojam, Duafalia F. Dudimah, Samuel T. Pellom et al. · Oncotarget · 2015 · 34 citations · Full text
Medicine, Immunology, Oncology +17
Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity
Anil Shanker, Samuel T. Pellom, Duafalia F. Dudimah et al. · Cancer Research · 2015 · 30 citations
Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function
Samuel T. Pellom, Duafalia F. Dudimah, Menaka C. Thounaojam et al. · Oncotarget · 2016 · 20 citations · Full text
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text
1–5 of 5